Monoaminergic Antidepressants in the Relief of Pain: Potential Therapeutic Utility of Triple Reuptake Inhibitors (TRIs)
Over 75% of depressed patients suffer from painful symptoms predicting a greater severity and a less favorable outcome of depression. Imaging, anatomical and functional studies have demonstrated the existence of common brain structures, neuronal pathways and neurotransmitters in depression and pain....
Saved in:
Main Authors: | Bruno P. Guiard (Author), Alain M. Gardier (Author), Guillaume Hache (Author), François Coudore (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Suicide attempt with selective serotonin reuptake inhibitor antidepressants
by: Sandra Cuenca Carcelén, et al.
Published: (2021) -
Pharmacological Characterization of Toludesvenlafaxine as a Triple Reuptake Inhibitor
by: Haibo Zhu, et al.
Published: (2021) -
The effect of triple reuptake inhibitor toludesvenlafaxine on neurological function in cerebral ischemic rats
by: Xiaohui Sun, et al.
Published: (2023) -
The antidepressant potential of (R)- (-)-Carvone involves antioxidant and monoaminergic mechanisms in mouse models
by: Mina Vahedi, et al.
Published: (2024) -
Computational Analysis of Therapeutic Neuroadaptation to Chronic Antidepressant in a Model of the Monoaminergic Neurotransmitter and Stress Hormone Systems
by: Mariam B. Camacho, et al.
Published: (2019)